Study of MDR-001 tablet for overweight or obese adults
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests a new tablet called MDR-001 for people who are overweight or obese. Researchers want to see if it is safe and helps with weight loss. You would take the tablet in different doses over several weeks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 55 years old.
- Your body mass index (BMI) is between 27 and 45.
- Your waist measurement is at least 90 cm (men) or 85 cm (women).
- You do not have certain health issues like bleeding problems, thyroid cancer history, or recent large weight changes.
- Your blood tests and heart check (ECG) show no major concerns.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental drug, MDR-001, to see if it is safe and helps with weight loss. It is for Chinese adults who are obese or overweight and have related health problems like pre-diabetes or high blood pressure.
This study tests a new medication called MDR-001 for helping people lose weight. It is for adults who are either obese or overweight with related health issues. The goal is to see if the drug is safe and effective for weight loss.
This trial tests an investigational weight-loss medication (MDR-001) for people who are overweight or have obesity. Researchers want to see if this drug helps with weight loss and is safe when taken along with diet and exercise.
This trial tests a new tablet, BGM0504, in healthy adults who are overweight or obese but do not have diabetes. It aims to see how the medicine works and if it is safe for this group.
This trial tests a new tablet called MWN109 in healthy adults to see how safe it is and how the body handles it. It has two parts: one for people with a wide range of body weights, and another specifically for people with higher body weight. The results will help guide future studies.
This study tests a new medicine called PF-08653945 to see how it enters the blood in adults who are overweight or have obesity. The results will help doctors understand how the medicine works in the body.
Hear when a new Overweight and Obese Volunteers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.